Search

Your search keyword '"Meijer, Gerrit A."' showing total 55 results

Search Constraints

Start Over You searched for: Author "Meijer, Gerrit A." Remove constraint Author: "Meijer, Gerrit A." Publisher wiley Remove constraint Publisher: wiley
55 results on '"Meijer, Gerrit A."'

Search Results

1. Polyketide synthase positive Escherichia coli one‐time measurement in stool is not informative of colorectal cancer risk in a screening setting

2. Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite‐instable colorectal cancers

3. A scenario‐drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology

4. Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice

5. The earliest events inBRAF‐mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathways

7. Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin’s lymphoma survivors

8. High CD8 + tumour‐infiltrating lymphocyte density associates with unfavourable prognosis in oesophageal adenocarcinoma following poor response to neoadjuvant chemoradiotherapy

9. A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype

10. Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid

12. Driver mutations occur frequently in metastases of well‐differentiated small intestine neuroendocrine tumours

13. Proteins in stool as biomarkers for non‐invasive detection of colorectal adenomas with high risk of progression

15. High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors

16. Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study

19. Recommendations for a step‐wise comparative approach to the evaluation of new screening tests for colorectal cancer

20. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients

22. Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence

25. Lack of microRNA‐101 causes E‐cadherin functional deregulation through EZH2 up‐regulation in intestinal gastric cancer

27. Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract

34. Candidate driver genes in focal chromosomal aberrations of stage II colon cancer

37. Copy number gain at 8q12.1‐q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas

38. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer

39. Comparative evaluation of genetic assays to identify oral pre-cancerous fields

46. Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high‐level amplifications

50. Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations

Catalog

Books, media, physical & digital resources